Efficacy and safety of bevacizumab combined chemotherapy in metastatic breast cancer: a Meta-analysis

DU Linjuan, LIU Shuang, LI Ming, WANG Chunguang

PDF(965 KB)
PDF(965 KB)
Tumor ›› 2021, Vol. 41 ›› Issue (03) : 197-205. DOI: 10.3781/j.issn.1000-7431.2021.33.835
Clinical Research

Efficacy and safety of bevacizumab combined chemotherapy in metastatic breast cancer: a Meta-analysis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 41(03): 197-205 https://doi.org/10.3781/j.issn.1000-7431.2021.33.835

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(965 KB)

Accesses

Citation

Detail

Sections
Recommended

/